AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION)
ACTION
Artificial Intelligence-assisted CT for Risk Stratification in COronary Artery Disease to PreveNt Future Coronary Events and Improve Outcomes
1 other identifier
observational
10,000
1 country
1
Brief Summary
The goal of this observational study is to learn if AI-assisted cardiac CT imaging can improve cardiovascular risk stratification and prediction of future coronary events in an adult population undergoing clinically indicated cardiac CT. The main questions it aims to answer are:
- Can AI-enhanced cardiac CT accurately assess cardiovascular risk in a real-world adult population?
- How do CT-derived plaque characteristics correlate with clinical, biochemical, and lifestyle risk factors? Researchers will compare subgroups (e.g., patients with different risk profiles, biomarkers, or imaging findings, and a subset undergoing OCT imaging) to see if differences in imaging and clinical parameters are associated with cardiovascular risk and plaque vulnerability. Participants will:
- Provide informed consent and medical history/demographic information
- Undergo blood sampling for cardiovascular and metabolic biomarkers
- Have a resting ECG performed
- Complete a detailed lifestyle and health questionnaire
- Receive a non-invasive cardiac CT scan interpreted by an expert
- Potentially receive heart rate-lowering medication (e.g., metoprolol) if required for imaging quality
- Be referred for further clinical evaluation if clinically indicated 
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 21, 2022
CompletedFirst Submitted
Initial submission to the registry
April 28, 2026
CompletedFirst Posted
Study publicly available on registry
May 11, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 21, 2032
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 21, 2032
May 11, 2026
May 1, 2026
10 years
April 28, 2026
May 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cardiovascular risk stratification using AI-assisted cardiac CT
Assessment of cardiovascular risk based on AI-enhanced cardiac CT imaging, including coronary artery calcium scoring, plaque characterization, and integrated risk prediction using clinical and imaging data.
Baseline
Secondary Outcomes (6)
Correlation between CT-derived plaque characteristics and haematological biomarkers
Baseline
Concordance between coronary CT angiography (CCTA) and optical coherence tomography (OCT)
Baseline (subset undergoing OCT)
Association between lifestyle factors and imaging-derived plaque risk features
Baseline
Subgroup analyses of cardiovascular risk by demographic and clinical factors
Baseline
Longitudinal changes in plaque composition in patients receiving statin therapy
Baseline, 1 year, and annually up to 5 years
- +1 more secondary outcomes
Other Outcomes (1)
Development of an anonymized multimodal dataset for AI training and validation
through study completion, up to 10 years
Eligibility Criteria
All-comers adult population undergoing clinically indicated cardiac CT in routine clinical care
You may qualify if:
- Adults aged ≥18 years
- Undergoing clinically indicated cardiac CT
- Able and willing to provide informed consent
You may not qualify if:
- History of malignancy
- Abnormal renal function (e.g., eGFR or serum creatinine outside reference range)
- Contraindications to iodinated contrast agents or CT imaging
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Galwaylead
- Science Foundation Irelandcollaborator
Study Sites (1)
Clinical Research Facility
Galway, Ireland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Faisal Sharif, MBBS, PhD, FRCPI, FESC, FACC
University of Galway
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 28, 2026
First Posted
May 11, 2026
Study Start
December 21, 2022
Primary Completion (Estimated)
December 21, 2032
Study Completion (Estimated)
December 21, 2032
Last Updated
May 11, 2026
Record last verified: 2026-05